Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""HEPATITIS B"" wg kryterium: Temat


Starter badań:

Tytuł :
Overt and occult hepatitis B infection after neonatal vaccination: mother-to-infant transmission and HBV vaccine effectiveness.
Autorzy :
Hu AQ; Department of Clinical Laboratory, Anqing Municipal Hospital, Anqing 246003, China.
Cai QY; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China; Institute of Microsurgery on Extremities, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
Zhang M; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China.
Liu HY; Department of Clinical Laboratory, Anqing Municipal Hospital, Anqing 246003, China.
Wang TL; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China.
Han WH; Department of Obstetrics and Gynecology, Anqing Municipal Hospital, Anqing 246003, China.
Li Q; Department of Obstetrics and Gynecology, Anqing Municipal Hospital, Anqing 246003, China.
Fan W; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China.
Li YJ; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China.
He YN; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China.
Zheng YJ; Department of Epidemiology, School of Public Health, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory for Health Technology Assessment, National Commission of Health and Family Planning, Fudan University, No.130 Dong'an Road, Xuhui District, Shanghai 200032, China; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai 200233, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Mar; Vol. 104, pp. 601-609. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B Vaccines*/immunology
Infectious Disease Transmission, Vertical*/prevention & control
Hepatitis B/*epidemiology
Hepatitis B/*transmission
Adult ; Female ; Hepatitis B/prevention & control ; Hepatitis B/virology ; Hepatitis B Surface Antigens/blood ; Hepatitis B virus/physiology ; Humans ; Infant ; Infant, Newborn ; Male ; Mothers ; Phylogeny ; Polymerase Chain Reaction ; Pregnancy ; Prenatal Diagnosis ; Prevalence ; Vaccination ; Viral Load
Czasopismo naukowe
Tytuł :
Real-world prevalence of hepatitis B virus reactivation in cancer patients in Taiwan.
Autorzy :
Chen CH; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.
Hsieh HH; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.
Wu TY; Department of Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.; Department of Pharmacology, School of Medicine, Tzu Chi University, Hualien, Taiwan.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jan; Vol. 27 (1), pp. 63-70. Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B virus*
Hepatitis B/*complications
Hepatitis B/*epidemiology
Neoplasms/*complications
Neoplasms/*epidemiology
Virus Activation/*drug effects
Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antiviral Agents/therapeutic use ; Female ; Hepatitis B/virology ; Hepatitis B Surface Antigens/analysis ; Humans ; Incidence ; Male ; Mass Screening ; Middle Aged ; Prevalence ; Retrospective Studies ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
Autorzy :
Seremba E; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. Electronic address: .
Ocama P; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Ssekitoleko R; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Mayanja-Kizza H; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Adams SV; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Orem J; Uganda Cancer Institute, Kampala, Uganda.
Katabira E; School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Reynolds SJ; Johns Hopkins University School of Medicine, USA; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Nabatanzi R; School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda.
Casper C; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Infectious Disease Research Institute Seattle, WA, USA; University of Washington, Seattle, WA, USA.
Phipps W; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Feb 22; Vol. 39 (8), pp. 1265-1271. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/complications
Hepatitis B*/complications
Hepatitis B*/prevention & control
Immunity, Humoral*
Hepatitis B Vaccines/*immunology
Adult ; Female ; Hepatitis B Antibodies ; Humans ; Male ; Uganda
Czasopismo naukowe
Tytuł :
Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss.
Autorzy :
Xue Y; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China.
Zhang M; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China.
Li T; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China.
Liu F; Department of Hepatology, Tianjin Second People's Hospital, Tianjin 300000, China.
Zhang LX; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China.
Fan XP; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China.
Yang BH; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China.
Wang L; Department of Infectious Disease and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, Shandong Province, China. .
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Apr 14; Vol. 27 (14), pp. 1497-1506.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B e Antigens*
Hepatitis B, Chronic*/diagnosis
Hepatitis B, Chronic*/drug therapy
Adult ; Antiviral Agents/therapeutic use ; DNA, Viral/therapeutic use ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Humans ; Male ; Recurrence ; Seroconversion ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.
Autorzy :
Hamida ME; Department of Microbiology, Orotta College of Medicine and Health Sciences (OCMHS), Asmara, Eritrea. .
Raja SM; Department of Internal Medicine, Orotta College of Medicine and Health Sciences (OCMHS), Asmara, Eritrea.
Seyoum Y; Department of Internal Medicine, Orotta College of Medicine and Health Sciences (OCMHS), Asmara, Eritrea.
Elkhidir IM; Department of Microbiology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Tekle F; Department of Immunoserology, National Health Laboratory (NHL), Asmara, Eritrea.
Pokaż więcej
Źródło :
BMC gastroenterology [BMC Gastroenterol] 2021 May 01; Vol. 21 (1), pp. 198. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B, Chronic*/diagnosis
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Adult ; Aged ; Child ; Cross-Sectional Studies ; DNA, Viral ; Eritrea/epidemiology ; Female ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Laboratories ; Male ; Middle Aged ; Prevalence
Czasopismo naukowe
Tytuł :
Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
Autorzy :
Tamandjou Tchuem CR; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: .
Andersson MI; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom. Electronic address: .
Wiysonge CS; South African Cochrane Centre, South African Medical Research Council, Cape Town, South Africa. Electronic address: .
Mufenda J; Department of Obstetrics and Gynaecology, Windhoek Hospital Complex, Windhoek, Namibia. Electronic address: .
Preiser W; Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Electronic address: .
Cleary S; Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 May 27; Vol. 39 (23), pp. 3141-3151. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Pregnancy Complications, Infectious*/prevention & control
Child ; Cost-Benefit Analysis ; Female ; Hepatitis B Surface Antigens ; Hepatitis B Vaccines ; Hepatitis B e Antigens ; Hepatitis B virus ; Humans ; Infant ; Infectious Disease Transmission, Vertical/prevention & control ; Namibia ; Pregnancy
Czasopismo naukowe
Tytuł :
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
Autorzy :
Ditto MC; Rheumatology Unit, Department of General and Specialistic Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, and University of Padova, PhD Program in Clinical and Experimental Sciences, Padova, Italy.
Parisi S; Rheumatology Unit, Department of General and Specialistic Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. .
Varisco V; Rheumatology Unit, Department of Internal Medicine, San Gerardo Hospital, Monza, Italy.
Talotta R; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Messina, Azienda Ospedaliera Gaetano Martino, Messina, Italy.
Batticciotto A; Rheumatology Unit, Department of Internal Medicine, Ospedale di Circolo - Fondazione Macchi, ASST-Settelaghi, Varese, Italy.
Antivalle M; Rheumatology Unit, University Hospital ASST-Fatebenefratelli-Sacco, Milan, Italy.
Gerardi MC; Rheumatology and Clinical Immunology Unit and Department of Clinical and Experimental Sciences, Spedali Civili and University of Brescia, Italy.
Agosti M; Rheumatology Unit, University Hospital ASST-Fatebenefratelli-Sacco, Milan, Italy.
Borrelli R; Rheumatology Unit, Department of General and Specialistic Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Fusaro E; Rheumatology Unit, Department of General and Specialistic Medicine, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Sarzi-Puttini P; Rheumatology Unit, University Hospital ASST-Fatebenefratelli-Sacco, Milan, Italy.
Pokaż więcej
Źródło :
Clinical and experimental rheumatology [Clin Exp Rheumatol] 2021 May-Jun; Vol. 39 (3), pp. 546-554. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Hepatitis B*/diagnosis
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis B virus*
Tumor Necrosis Factor Inhibitors*/immunology
Tumor Necrosis Factor Inhibitors*/therapeutic use
Virus Activation*
Antiviral Agents/*therapeutic use
Arthritis, Rheumatoid/*immunology
Arthritis, Rheumatoid/therapy ; Biological Therapy ; Hepatitis B Antibodies/pharmacology ; Hepatitis B Antibodies/therapeutic use ; Hepatitis B Surface Antigens ; Humans ; Prevalence
Czasopismo naukowe
Tytuł :
Serum hepatitis B virus ribonucleic acid and its influencing factors in chronic hepatitis B.
Autorzy :
Zhou Y; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Peng Y; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Yuan H; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Long Z; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Wu S; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Yang J; Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.
Pokaż więcej
Źródło :
Advances in clinical and experimental medicine : official organ Wroclaw Medical University [Adv Clin Exp Med] 2021 Apr; Vol. 30 (4), pp. 361-367.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B virus*/genetics
Hepatitis B, Chronic*/diagnosis
DNA, Viral/genetics ; Hepatitis B e Antigens ; Humans ; RNA
Czasopismo naukowe
Tytuł :
[Effect of tenofovir disoproxil fumarate antiviral therapy on virus-specific CD8+T Cells function in patients with chronic hepatitis B].
Autorzy :
Duan SP; Department of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Zhu LH; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Hou LJ; Department of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Wang HW; Department of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Zhu XW; Department of Infectious Diseases, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Hao J; Medical Section, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 May 20; Vol. 29 (5), pp. 421-426.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; CD8-Positive T-Lymphocytes ; DNA, Viral ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Tenofovir/therapeutic use ; Treatment Outcome ; Viral Load
Czasopismo naukowe
Tytuł :
LCR based quick detection of hotspot G1896A mutation in patients with different spectrum of hepatitis B.
Autorzy :
Malik A; Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Electronic address: .
Aldakheel F; Department of Clinical Laboratory Science, College of Applied Medical Science, King Saud University, Riyadh, 11564, Saudi Arabia; Prince Sattam Chair for Epidemiology and Public Health Research, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Rabbani S; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alshehri M; Department of Clinical Laboratory Science, College of Applied Medical Science, King Saud University, Riyadh, 11564, Saudi Arabia.
Chaudhary AA; Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Alkholief M; Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Alshamsan A; Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło :
Journal of infection and public health [J Infect Public Health] 2021 May; Vol. 14 (5), pp. 651-654. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*
Hepatitis B, Chronic*
DNA, Viral/genetics ; Hepatitis B virus/genetics ; Humans ; Mutation ; Polymerase Chain Reaction
Czasopismo naukowe
Tytuł :
Hepatitis B reverse seroconversion despite entecavir prophylaxis in a myeloma patient on multiple novel agents: a case report and review of the literature.
Autorzy :
Reynolds G; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.
Stewart T; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.
Harrison SJ; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
Spencer A; Department of Malignant Haematology and Stem Cell Transplantation, Alfred Health, Melbourne, Australia.
Teh BW; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; National Centre for Infections in Cancer, Melbourne, Australia.
Pokaż więcej
Źródło :
Leukemia & lymphoma [Leuk Lymphoma] 2021 May; Vol. 62 (5), pp. 1271-1274. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji :
Case Reports; Letter; Review
MeSH Terms :
Hepatitis B*/complications
Hepatitis B*/drug therapy
Hepatitis B*/prevention & control
Multiple Myeloma*/complications
Multiple Myeloma*/drug therapy
Antiviral Agents/therapeutic use ; DNA, Viral ; Guanine/analogs & derivatives ; Guanine/therapeutic use ; Hepatitis B e Antigens ; Hepatitis B virus ; Humans ; Seroconversion ; Treatment Outcome
Recenzja
Tytuł :
Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B.
Autorzy :
Goh ZY; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Ren EC; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
Ko HL; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore. .
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Apr 14; Vol. 27 (14), pp. 1369-1391.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hepatitis B*
Hepatitis B, Chronic*/drug therapy
Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; DNA, Circular ; DNA, Viral/genetics ; DNA, Viral/therapeutic use ; Hepatitis B virus/genetics ; Humans ; Interferons/therapeutic use ; Virus Replication
Czasopismo naukowe
Tytuł :
COVID-19 Patients With Hepatitis B Virus Infection.
Autorzy :
Lv XH; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Gastroenterology & Hepatology, Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Yang JL; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Gastroenterology & Hepatology, Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Deng K; Department of Gastroenterology & Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Gastroenterology & Hepatology, Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; COVID-19 Medical Team (Hubei) of West China Hospital, Sichuan University, Chengdu, Sichuan, China.; COVID-19 Medical Team (Hubei) of West China Hospital, East Branch of Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2021 Jun 01; Vol. 116 (6), pp. 1357-1358.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*
Hepatitis B*
Hepatitis B, Chronic*/complications
Hepatitis B virus ; Humans ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Debate settled for elevated alanine aminotransferase in hepatitis B?
Autorzy :
Chan HL; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Jun; Vol. 21 (6), pp. 750-751. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hepatitis B*
Hepatitis B, Chronic*
Alanine Transaminase ; Double-Blind Method ; Hepatitis B virus ; Humans ; Tenofovir
Czasopismo naukowe
Tytuł :
Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.
Autorzy :
Yang DH; Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China. .
Wang WP; Postgraduate Department, Bengbu Medical College, Bengbu 233030, Anhui Province, China.
Zhang Q; Postgraduate Department, Bengbu Medical College, Bengbu 233030, Anhui Province, China.
Pan HY; Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Huang YC; Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Zhang JJ; Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, Zhejiang Province, China.
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 May 07; Vol. 27 (17), pp. 2025-2038.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/epidemiology
Cross-Sectional Studies ; Hepatitis B virus ; Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/epidemiology ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Seroconversion rate following HBV vaccination in clinical practice: The role of age and DMT treatment.
Autorzy :
Faustino P; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Coutinho M; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Leitão L; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Capela C; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Brum M; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Parra J; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Sequeira J; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal; Neurology Department, Centro Hospitalar Barreiro Montijo, Portugal.
Barros A; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Araújo C; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Sousa A; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal.
Ladeira F; Neurology Department, Centro Hospitalar Universitário de Lisboa Central, Portugal. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 May; Vol. 50, pp. 102859. Date of Electronic Publication: 2021 Feb 23.
Typ publikacji :
Letter
MeSH Terms :
Hepatitis B Antibodies*
Hepatitis B virus*
Aged ; Cohort Studies ; Hepatitis B Vaccines ; Humans ; Middle Aged ; Seroconversion ; Vaccination
Opinia redakcyjna
Tytuł :
Outcomes of acute hepatitis B virus (HBV) in HIV infection with and without HBV-active antiretroviral therapy.
Autorzy :
Falade-Nwulia O; Johns Hopkins University, Baltimore, Maryland.
Seaberg EC; Johns Hopkins University, Baltimore, Maryland.
Snider AE; Johns Hopkins University, Baltimore, Maryland.
Rinaldo CR; Departments of Pathology and Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Wolinsky SM; Department of Medicine, Feinberg School of Medicine, Northwestern University Chicago, Chicago, Illinois.
Witt MD; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Thio CL; Johns Hopkins University, Baltimore, Maryland.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 May 01; Vol. 35 (6), pp. 991-993.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
HIV Infections*/complications
HIV Infections*/drug therapy
Hepatitis B*/complications
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Antiretroviral Therapy, Highly Active ; Cohort Studies ; Hepatitis B virus ; Humans ; Male
Czasopismo naukowe
Tytuł :
Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review.
Autorzy :
Carrión-Barberà I; Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain. .
Pros A; Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Salman-Monte TC; Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Vílchez-Oya F; Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Sánchez-Schmidt JM; Dermatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Pérez-García C; Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Monfort J; Rheumatology Department, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain.
Pokaż więcej
Źródło :
Clinical rheumatology [Clin Rheumatol] 2021 May; Vol. 40 (5), pp. 2065-2070. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Hepatitis B*/complications
Hepatitis B*/drug therapy
Polyarteritis Nodosa*/complications
Polyarteritis Nodosa*/drug therapy
Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Female ; Hepatitis B virus ; Humans
Czasopismo naukowe
Tytuł :
[Risk assessment and management of hepatocellular carcinoma occurrence in patients with chronic hepatitis B in the era of antiviral therapy].
Autorzy :
Xin HG; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Xie Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Apr 20; Vol. 29 (4), pp. 297-300.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Antiviral Agents/therapeutic use ; China ; Hepatitis B virus ; Humans ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
[Oral nucleos(t)ide analogues antiviral therapy reduces HBV-related HCC: consensus and contention].
Autorzy :
Han C; Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Dou XG; Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Apr 20; Vol. 29 (4), pp. 293-296.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/etiology
Liver Neoplasms*/prevention & control
Antiviral Agents/therapeutic use ; Consensus ; Hepatitis B virus ; Humans
Czasopismo naukowe
Tytuł :
Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
Autorzy :
Preininger L; William J. Holloway Community Program, Christiana Care Health System, Wilmington, Delaware, USA.
Kahal DA
Szabo S
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 Apr 01; Vol. 35 (5), pp. 845-846.
Typ publikacji :
Journal Article
MeSH Terms :
HIV Infections*/drug therapy
Hepatitis B*/prevention & control
Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Hepatitis B Vaccines ; Humans ; Vaccination
Czasopismo naukowe
Tytuł :
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
Autorzy :
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Hsu CY; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Hong CM; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tsai CH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen HH; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Apr; Vol. 53 (8), pp. 908-918. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B, Chronic*/complications
DNA, Viral ; Disease Progression ; Hepatitis B Core Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Symptom Flare Up ; Viral Load
Czasopismo naukowe
Tytuł :
Tenofovir-induced osteomalacia with hypophosphataemia.
Autorzy :
Iatan I; General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Lee TC; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
McDonald EG; General Internal Medicine, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada .; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 May 24; Vol. 14 (5). Date of Electronic Publication: 2021 May 24.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Fanconi Syndrome*/chemically induced
Fanconi Syndrome*/diagnosis
Fanconi Syndrome*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Hepatitis B, Chronic*/drug therapy
Hypophosphatemia*/chemically induced
Hypophosphatemia*/diagnosis
Hypophosphatemia*/drug therapy
Osteomalacia*/chemically induced
Osteomalacia*/diagnosis
Osteomalacia*/drug therapy
Antiviral Agents/therapeutic use ; Female ; Hepatitis B virus ; Humans ; Middle Aged ; Tenofovir/adverse effects
Czasopismo naukowe
Tytuł :
Hepatitis B virus infection associated with polyarteritis nodosa and microscopic polyangiitis.
Autorzy :
Meng Z; Department of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, Maryland, USA.
Cui W; Integrated Medical Care, L.L.C, Rockville, Maryland, USA.
Arend L; Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Mikdashi J; Department of Medicine, University of Maryland Medical Center Midtown Campus, Baltimore, Maryland, USA .; Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 May 19; Vol. 14 (5). Date of Electronic Publication: 2021 May 19.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hepatitis B*/complications
Hepatitis B*/drug therapy
Microscopic Polyangiitis*/complications
Microscopic Polyangiitis*/diagnosis
Microscopic Polyangiitis*/drug therapy
Polyarteritis Nodosa*/complications
Polyarteritis Nodosa*/diagnosis
Polyarteritis Nodosa*/drug therapy
Aged ; Antibodies, Antineutrophil Cytoplasmic ; Hepatitis B virus ; Humans ; Male
Czasopismo naukowe
Tytuł :
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.
Autorzy :
Pol S; Université de Paris and Département d'Hépatologie, APHP, Hôpital Cochin, Paris, France.
Lusivika Nzinga C; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, IPLESP, Paris, France.
Carrat F; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, IPLESP, Sorbonne Université, Paris, France.; AP-HP. Sorbonne Université, Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 May; Vol. 53 (9), pp. 1050.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Antiviral Agents/therapeutic use ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Tenofovir/therapeutic use
Opinia redakcyjna
Tytuł :
Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients.
Autorzy :
Wang JG; Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Chen R; Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Wang LC; Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 May; Vol. 53 (9), pp. 1048-1049.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Antiviral Agents/therapeutic use ; Guanine/analogs & derivatives ; Hepatitis B virus ; Humans ; Tenofovir/therapeutic use
Opinia redakcyjna
Tytuł :
Switching-peptides for one-step immunoassay and its application to the diagnosis of human hepatitis B.
Autorzy :
Bong JH; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Kim HR; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Jung J; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Park JH; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Sung JS; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Lee CK; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Choi KH; OPTOLANE Technologies Inc., 20 Pangyoyeok-ro 241beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea.
Shin SS; OPTOLANE Technologies Inc., 20 Pangyoyeok-ro 241beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea.
Kang MJ; Korea Institute of Science and Technology (KIST), 5 Hwarang-ro 14-gil, Seongbuk-gu, Seoul, 02792, Republic of Korea.
Kim HO; Department of Laboratory Medicine, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Lee DY; OPTOLANE Technologies Inc., 20 Pangyoyeok-ro 241beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13494, Republic of Korea.
Pyun JC; Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Biosensors & bioelectronics [Biosens Bioelectron] 2021 Apr 15; Vol. 178, pp. 112996. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Biosensing Techniques*
Hepatitis B*/diagnosis
Immunoassay*
Peptides*/analysis
Animals ; Hepatitis B Surface Antigens ; Humans
Czasopismo naukowe
Tytuł :
[Progress in the research of HBV reactivation in patients undergoing hematopoietic stem cell transplantation].
Autorzy :
Niu JX; Department of Hematology, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Xu Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Wu DP; Department of Hematology, The First Affiliated Hospital of Soochow University, Medical College of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, China.
Pokaż więcej
Źródło :
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2021 Apr 14; Vol. 42 (4), pp. 348-352.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Hepatitis B virus*
Hepatitis B Surface Antigens ; Humans ; Virus Activation
Czasopismo naukowe
Tytuł :
Reply to: 'Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action'.
Autorzy :
Gonçalves A; Université de Paris, IAME, INSERM, Paris, France.
Lemenuel-Diot A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
Guedj J; Université de Paris, IAME, INSERM, Paris, France.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Apr; Vol. 28 (4), pp. 689-690. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Letter; Comment
MeSH Terms :
Hepatitis B virus*/genetics
RNA*
Hepatitis B e Antigens ; Humans ; Kinetics ; Nucleosides
Opinia redakcyjna
Tytuł :
Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed.
Autorzy :
Dahari H; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
Shlomai A; Beilinson Hospital, Department of Medicine D and The Liver Institute, Rabin Medical Center, Petah-Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Cotler SJ; The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Apr; Vol. 28 (4), pp. 687-688. Date of Electronic Publication: 2021 Jan 15.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Hepatitis B virus*/genetics
RNA*
DNA, Viral ; Hepatitis B e Antigens ; Humans ; Kinetics
Raport
Tytuł :
Screening for Hepatitis B in Nonpregnant Adolescents and Adults.
Autorzy :
Jin J; Associate Editor, JAMA.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Dec 15; Vol. 324 (23), pp. 2452.
Typ publikacji :
Patient Education Handout
MeSH Terms :
Hepatitis B virus*/immunology
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*diagnosis
Mass Screening/*standards
Adolescent ; Adult ; Hepatitis B Vaccines ; Humans ; Mass Screening/adverse effects ; Risk Factors
Tytuł :
Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.
Autorzy :
Krist AH; Fairfax Family Practice Residency, Fairfax, Virginia.; Virginia Commonwealth University, Richmond.
Davidson KW; Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
Mangione CM; University of California, Los Angeles.
Barry MJ; Harvard Medical School, Boston, Massachusetts.
Cabana M; University of California, San Francisco.
Caughey AB; Oregon Health & Science University, Portland.
Donahue K; University of North Carolina at Chapel Hill.
Doubeni CA; Mayo Clinic, Rochester, Minnesota.
Epling JW Jr; Virginia Tech Carilion School of Medicine, Roanoke.
Kubik M; George Mason University, Fairfax, Virginia.
Ogedegbe G; New York University, New York, New York.
Owens DK; Stanford University, Stanford, California.
Pbert L; University of Massachusetts Medical School, Worcester.
Silverstein M; Boston University, Boston, Massachusetts.
Simon MA; Northwestern University, Evanston, Illinois.
Tseng CW; University of Hawaii, Honolulu.; Pacific Health Research and Education Institute, Honolulu, Hawaii.
Wong JB; Tufts University School of Medicine, Boston, Massachusetts.
Pokaż więcej
Corporate Authors :
US Preventive Services Task Force
Źródło :
JAMA [JAMA] 2020 Dec 15; Vol. 324 (23), pp. 2415-2422.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B virus*/immunology
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*diagnosis
Mass Screening/*standards
Adolescent ; Adult ; Emigrants and Immigrants ; Hepatitis B Vaccines ; Humans ; Mass Screening/adverse effects ; Risk Factors ; United States
Czasopismo naukowe
Tytuł :
Seroprevalence of Hepatitis B Infection Among a Population of Blood Donors in the Kpandai District of Northern Ghana: A Five-Year Retrospective Study from 2014 to 2018.
Autorzy :
Bawah AT; Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana. .
Kinanyok S; Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Abaka-Yawson A; Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Mwintumah B; Kpandai District Hospital, P.O. Box 35, Kpandai, Ghana.
Ngambire LT; GRA Custom Division, P. O. Box KF304, Koforidua, Ghana.
Darko R; Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Hamid AM; Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Pokaż więcej
Źródło :
Journal of community health [J Community Health] 2020 Dec; Vol. 45 (6), pp. 1220-1227.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B virus*
Hepatitis B/*epidemiology
Adolescent ; Adult ; Blood Donors/statistics & numerical data ; Female ; Ghana/epidemiology ; Hepatitis B Surface Antigens/blood ; Humans ; Male ; Middle Aged ; Prevalence ; Retrospective Studies ; Seroepidemiologic Studies
Czasopismo naukowe
Tytuł :
Transplanting Kidneys From Donors With Chronic Hepatitis B: Bringing Transmission Risk Closer to Zero.
Autorzy :
Terrault NA; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Mar 15; Vol. 72 (6), pp. 1024-1025.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Hepatitis B, Chronic*/epidemiology
Hepatitis B, Chronic*/prevention & control
Kidney Transplantation*
China ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Humans ; Kidney ; Living Donors ; Tissue Donors
Czasopismo naukowe
Tytuł :
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
Autorzy :
Nayagam S; Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom.; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London,UK.
Chan P; World Health Organization China office, Beijing, China.
Zhao K; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Sicuri E; Health Economics Group, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Wang X; National Center for AIDS Control and Prevention (NCAIDS), China Center for Disease Control and Prevention, Beijing, China.
Jia J; Liver Research Center, Beijing Friendship Hospital, Beijing, China.
Wei L; Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
Walsh N; World Health Organization regional office for the Western Pacific, Manila, Philippines.
Rodewald LE; World Health Organization China office, Beijing, China.
Zhang G; National Immunization Programme, China Center for Disease Control and Prevention, Beijing, China.
Ailing W; National Center for Women and Children's Health, China Center for Disease Control and Prevention, Beijing, China.
Zhang L; World Health Organization China office, Beijing, China.
Chang JH; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Hou W; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Qiu Y; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Sui B; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Xiao Y; China National Health Development Research Center, National Health and Family Planning Commission, Beijing, China.
Zhuang H; Department of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.
Thursz MR; Section of Hepatology and Gastroenterology, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom.
Scano F; World Health Organization China office, Beijing, China.
Low-Beer D; World Health Organization, Geneva, Switzerland.
Schwartländer B; World Health Organization, Geneva, Switzerland.
Wang Y; China Center for Disease Control and Prevention, Beijing, China.
Hallett TB; MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London,UK.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Mar 01; Vol. 72 (5), pp. 743-752.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Hepatitis B, Chronic*/prevention & control
Antiviral Agents/therapeutic use ; China/epidemiology ; Hepatitis B Vaccines/therapeutic use ; Hepatitis B virus ; Humans
Czasopismo naukowe
Tytuł :
Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study.
Autorzy :
Atsmon J; Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel.
Machluf N; SciVac Ltd., Rehovot 7610303, Israel.
Yayon-Gur V; SciVac Ltd., Rehovot 7610303, Israel.
Sabbah C; SciVac Ltd., Rehovot 7610303, Israel.
Spaans JN; VBI Vaccines Inc., Cambridge, MA, United States.
Yassin-Rajkumar B; VBI Vaccines Inc., Cambridge, MA, United States.
Anderson DE; VBI Vaccines Inc., Cambridge, MA, United States.
Popovic V; VBI Vaccines Inc., Cambridge, MA, United States.
Diaz-Mitoma F; VBI Vaccines Inc., Cambridge, MA, United States. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Feb 22; Vol. 39 (8), pp. 1328-1332. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B*/prevention & control
Hepatitis B Vaccines*
Adult ; Hepatitis B Antibodies ; Hepatitis B Surface Antigens ; Humans ; Immunization, Secondary ; Young Adult
Czasopismo naukowe
Tytuł :
[A 2020 update on the progress of treatment and new drug clinical trials for hepatitis B].
Autorzy :
Jia JD; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing 100050, China.
Niu JQ; Department of Hepatology & Phase I Clinical Research Center, The First Hospital of Jilin University, Changchun 130021, China.
You H; Liver Research Center, Beijing Friendship Hospital, Capital Medical University; Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis, Beijing 100050, China.
Kong YY; Clinical Epidemiology & EBM Unit, National Clinical Research Center for Digestive Diseases; Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Hou JL; Clinical Epidemiology & EBM Unit, National Clinical Research Center for Digestive Diseases; Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Feb 20; Vol. 29 (2), pp. 97-101.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*/drug therapy
Hepatitis B, Chronic*/drug therapy
Pharmaceutical Preparations*
Antiviral Agents/therapeutic use ; DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans
Czasopismo naukowe
Tytuł :
Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study.
Autorzy :
Li M; School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P. R. China.
Zu J; School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P. R. China. .
Shen M; School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, P. R. China.
Zhuang G; School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, P. R. China.
Chen S; Department of Statistics and Actuarial Science, Simon Fraser University, V5A1S6, Burnaby, British Columbia, Canada.
Wang F; Chinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China.
Zheng H; Chinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China.
Zhang G; Chinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China. .
Pokaż więcej
Źródło :
BMC public health [BMC Public Health] 2021 Feb 19; Vol. 21 (1), pp. 388. Date of Electronic Publication: 2021 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B*/epidemiology
Hepatitis B virus*
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; China/epidemiology ; Female ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Prevalence ; Young Adult
Czasopismo naukowe
Tytuł :
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B.
Autorzy :
Lee HW; Department of Internal medicine, Yonsei University College of medicine, Seoul, Republic of Korea; Institute of Gastroenterology, Yonsei University College of medicine, Seoul, Republic of Korea; Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.
Chon YE; Department of Internal Medicine, Cha Bundang Medical Center, Cha University, Seongnam, Republic of Korea.
Kim BK; Department of Internal medicine, Yonsei University College of medicine, Seoul, Republic of Korea; Institute of Gastroenterology, Yonsei University College of medicine, Seoul, Republic of Korea; Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea.
Yip TC; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China.
Tse YK; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China.
Wong GL; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China.
Wong VW; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China.
Chan HL; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong; Hong Kong SAR, China. Electronic address: .
Ahn SH; Department of Internal medicine, Yonsei University College of medicine, Seoul, Republic of Korea; Institute of Gastroenterology, Yonsei University College of medicine, Seoul, Republic of Korea; Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
European journal of internal medicine [Eur J Intern Med] 2021 Feb; Vol. 84, pp. 68-73. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Liver Neoplasms*/epidemiology
Antiviral Agents/therapeutic use ; DNA, Viral ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans
Czasopismo naukowe
Tytuł :
Effect of alcohol on the progress of hepatitis B cirrhosis.
Autorzy :
Zhou E; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yang C; Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Email: .
Gao Y; School of Public Health and Management, Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2021 Jan; Vol. 10 (1), pp. 415-424.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*
Hepatitis B, Chronic*
Hepatitis B Surface Antigens ; Hepatitis B virus ; Humans ; Liver Cirrhosis
Czasopismo naukowe
Tytuł :
SERS-based viral load quantification of hepatitis B virus from PCR products.
Autorzy :
Batool F; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Nawaz H; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan. Electronic address: .
Majeed MI; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan. Electronic address: .
Rashid N; Department of Chemistry, University of Central Punjab, Lahore, Faisalabad Campus, Pakistan.
Bashir S; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Akbar S; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Abubakar M; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Ahmad S; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Ashraf MN; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Ali S; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Kashif M; Department of Chemistry, University of Agriculture, Faisalabad 38040, Pakistan.
Amin I; PCR Laboratory, PINUM Hospital, Faisalabad, Pakistan.
Pokaż więcej
Źródło :
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2021 Jul 05; Vol. 255, pp. 119722. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*/diagnosis
Hepatitis B, Chronic*
Liver Neoplasms*
DNA, Viral/genetics ; Hepatitis B virus/genetics ; Humans ; Polymerase Chain Reaction ; Viral Load
Czasopismo naukowe
Tytuł :
Long-term follow-up of cumulative incidence of hepatocellular carcinoma in hepatitis B virus patients without antiviral therapy.
Autorzy :
Jiang XY; Department of Gastroenterology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Huang B; Department of Gastroenterology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Huang DP; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Wei CS; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Zhong WC; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Peng DT; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Huang FR; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.
Tong GD; Department of Hepatology, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China. .
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Mar 21; Vol. 27 (11), pp. 1101-1116.
Typ publikacji :
Clinical Trial
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/epidemiology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/diagnosis
Hepatitis B, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Liver Neoplasms*/epidemiology
Adult ; Antiviral Agents/therapeutic use ; China/epidemiology ; Follow-Up Studies ; Hepatitis B e Antigens ; Hepatitis B virus ; Humans ; Incidence ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/epidemiology ; Male
Raport
Tytuł :
[New insights into immunotolerant phase of chronic hepatitis B virus infection].
Autorzy :
Duan MH; Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Liu XE; Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Zhuang H; Department of Microbiology and Center of Infectious Diseases, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Pokaż więcej
Źródło :
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2021 Mar 20; Vol. 29 (3), pp. 284-288.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B, Chronic*
Liver Neoplasms*
DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Immune Tolerance
Czasopismo naukowe
Tytuł :
First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients.
Autorzy :
Mak LY; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road 102,, Pok Fu Lam, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Wong DK; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road 102,, Pok Fu Lam, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Cheung KS; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road 102,, Pok Fu Lam, Hong Kong.; Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Seto WK; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road 102,, Pok Fu Lam, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Fung J; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road 102,, Pok Fu Lam, Hong Kong.; State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Yuen MF; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road 102,, Pok Fu Lam, Hong Kong. .; State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong. .
Pokaż więcej
Źródło :
BMC gastroenterology [BMC Gastroenterol] 2021 Mar 17; Vol. 21 (1), pp. 123. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; DNA, Viral ; Hepatitis B Core Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Japan ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis.
Autorzy :
Brunetto MR; Pisa, Italy.
Carey I; London, UK.
Maasoumy B; Hannover, Germany.
Marcos-Fosch C; Barcelona, Spain.
Boonstra A; Rotterdam, the Netherlands.
Caviglia GP; Turin, Italy.
Loglio A; Milan, Italy.
Cavallone D; Pisa, Italy.
Scholtes C; Lyon, France.
Ricco G; Pisa, Italy.
Smedile A; Turin, Italy.
Riveiro-Barciela M; Barcelona, Spain.
van Bömmel F; Leipzig, Germany.
van der Eijk A; Rotterdam, the Netherlands.
Zoulim F; Lyon, France.
Berg T; Leipzig, Germany.
Cornberg M; Hannover, Germany.
Lampertico P; Milan, Italy.
Agarwal K; London, UK.
Buti M; Barcelona, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Mar; Vol. 53 (6), pp. 733-744. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B e Antigens*
Hepatitis B, Chronic*/diagnosis
Adult ; DNA, Viral/genetics ; Female ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Humans ; Male ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Method for detecting hepatitis B virus in blood plasma at low viral load using real-time PCR.
Autorzy :
Serikova EN; Saint-Petersburg Pasteur Institute.
Semenov AV; Saint-Petersburg Pasteur Institute.; Saint-Petersburg State Medical University n.a. acad. I.P. Pavlov.; North-West State Medical University n.a. I.I. Mechnikov.
Ostankova YV; Saint-Petersburg Pasteur Institute.
Totolian AA; Saint-Petersburg Pasteur Institute.; Saint-Petersburg State Medical University n.a. acad. I.P. Pavlov.
Pokaż więcej
Transliterated Title :
Метод выявления вируса гепатита B в плазме крови при низкой вирусной нагрузке с использованием ПЦР в режиме реального времени.
Źródło :
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2021 Feb 10; Vol. 66 (1), pp. 59-64.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis B virus*/genetics
Blood Donors ; DNA, Viral/genetics ; Female ; Hepatitis B Surface Antigens/genetics ; Humans ; Plasma ; Pregnancy ; Real-Time Polymerase Chain Reaction ; Russia ; Viral Load
Czasopismo naukowe
Tytuł :
Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening.
Autorzy :
Chang KC; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Lee CY; Department of Laboratory Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chang TS; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Yunlin, Taiwan; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Hung CH; Department of Internal Medicine, Division of Hepato-Gastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan.
Chen WM; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chen MY; College of Nursing, Chang Gung University of Science and Technology, Chiayi, Taiwan.
Huang TJ; Division of Thoracic Medicine, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Chiu WN; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Hu JH; Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Lin YC; Division of Family Medicine, Chang Gung Memorial Hospital, Yunlin, Taiwan.
Huang WC; Department of Geriatric, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Hsu NT; Biostatistics and Bioinformatics Center of Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lu SN; Department of Internal Medicine, Division of Hepato-Gastroenterology, Kaohsiung Chang Gung Memorial Hospital, Taiwan; Biostatistics and Bioinformatics Center of Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2021 Feb; Vol. 120 (2), pp. 847-853. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Hepatitis B*/diagnosis
DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Taiwan ; Viral Load
Czasopismo naukowe
Tytuł :
Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B.
Autorzy :
Farag MS; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.; Institute of Medical Science, University of Toronto, Toronto, Canada.
van Campenhout MJH; Department of Gastroenterology and Hepatology, Erasmus Medical Centre Rotterdam, Rotterdam, Netherlands.
Pfefferkorn M; University Hospital Leipzig, Department of Gastroenterology and Rheumatology, Section of Hepatology, Leipzig, Germany.
Fischer J; University Hospital Leipzig, Department of Gastroenterology and Rheumatology, Section of Hepatology, Leipzig, Germany.
Deichsel D; University Hospital Leipzig, Department of Gastroenterology and Rheumatology, Section of Hepatology, Leipzig, Germany.
Boonstra A; Department of Gastroenterology and Hepatology, Erasmus Medical Centre Rotterdam, Rotterdam, Netherlands.
van Vuuren AJ; Department of Gastroenterology and Hepatology, Erasmus Medical Centre Rotterdam, Rotterdam, Netherlands.
Ferenci P; Department of Internal Medicine 3, Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Feld JJ; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.
Berg T; University Hospital Leipzig, Department of Gastroenterology and Rheumatology, Section of Hepatology, Leipzig, Germany.
Hansen BE; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
van Bömmel F; University Hospital Leipzig, Department of Gastroenterology and Rheumatology, Section of Hepatology, Leipzig, Germany.
Janssen HLA; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Canada.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jan 27; Vol. 72 (2), pp. 202-211.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B virus*/genetics
Hepatitis B, Chronic*/diagnosis
Hepatitis B, Chronic*/drug therapy
Antiviral Agents/*therapeutic use
Interferon-alpha/*therapeutic use
Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Humans ; Polyethylene Glycols/therapeutic use ; RNA, Viral/analysis ; Recombinant Proteins/therapeutic use
Czasopismo naukowe
Tytuł :
Serum vitamin D and vitamin-D-binding protein levels in children with chronic hepatitis B.
Autorzy :
Huang CZ; Department of Laboratory Medicine, Hunan Children's Hospital, Changsha 410007, Hunan Province, China.
Zhang J; Department of Laboratory Medicine, Hunan Children's Hospital, Changsha 410007, Hunan Province, China.
Zhang L; Department of Laboratory Medicine, Hunan Children's Hospital, Changsha 410007, Hunan Province, China.
Yu CH; Department of GCP Certified Sites, The Third Hospital of Changsha City, Changsha 410005, Hunan Province, China.
Mo Y; Department of Laboratory Medicine, Hunan Children's Hospital, Changsha 410007, Hunan Province, China.
Mo LY; Department of Laboratory Medicine, Hunan Children's Hospital, Changsha 410007, Hunan Province, China. .
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Jan 21; Vol. 27 (3), pp. 255-266.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis B, Chronic*/diagnosis
Child ; DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Vitamin D ; Vitamin D-Binding Protein ; Vitamins
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies